From my own experience, the most valuable thing was to recognise there’s an issue and deal with it. At Novartis, we were surprised initially in the new organisation. We put in a lot of new processes that just weren’t gaining traction, so we did some investigation. We discovered 70% of our first-line managers — and at that time, there were a thousand first-line managers — had never had any formal training in how you act as a manager. So, over a year, we put in place a three-module first-line manager training programme; everyone had to go through it. That’s a huge investment, a huge commitment, but that was the commitment the firm was making, having understood what the issue is, to then address it.
Many, many, many managers — in this case, some 70%. And by the way, I’ve tested that in other companies, and they say, “Yeah, I’m sure that’ll be about where we are too.” Never given any proper training, so it’s a bit like swimming; taking someone who’s never swam before and throwing them in the pool. “Hope they’ll be able to figure it out; if not, well, they’ll bobble around and gasp a bit, but hopefully, they’ll reach the side of the pool,” versus, “Let’s learn how to swim.” What are we teaching? The fundamentals of people management, be it setting goals, holding people accountable to goals, how you build a team, how you coach, how you give feedback, when you give feedback.
These basic things, for some people, come very naturally. For most of us, they are not natural. We haven’t necessarily been educated in that way. And so, when you’re asked to do it for the first time, it’s quite nerve-wracking for most first-line managers. They’re really unsure — more unsure than the person sitting across the desk from them when they first give their bit of feedback. Overcoming that, supporting people is the first thing and probably, the most important thing.
You mean coaching from your boss? Very important. If you go back to one of the characteristics that differentiates the distinctive good leaders, the fact they focus on people; I will guarantee you, they will be giving feedback.
A guy I taught, Thomas Ebeling, fascinating guy. Psychologist by training, he’s German, hired by PepsiCo. He was country general manager for PepsiCo in Germany. He was then hired by Novartis into consumer health, which made sense; that’s a consumer-facing business. Danial Vasella, my boss and his, appointed him head of the pharmaceutical business in 2000. He’d been in the company two or three years. Sometimes, we talk about risk appointments; that was a seriously high-risk appointment. Thomas was not a scientist. It’s a business that is science-driven. It’s also a business that has very significant statutory requirements that have to be adhered to.
So, not a scientist, not a lawyer, and no pharmaceutical experience. If you jump to the end of the story, he mastered that business. He led it for ten years, top and bottom, double-digit, both lines, and he built a cadre of people which today, we could look at all the pharma companies around the world, and you will find some of Thomas’ guys running those businesses. A terrific cadre of people that he built because of this intense focus on people.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities.
© 2024 IP 1 Ltd. All rights reserved.